INSL4 and non-small cell lung carcinoma: In all NSCLC patients, high INSL4 expression was significantly associated with shortened Overall Survival (OS, P=0.00094, HR=1.24) as well as with reduced First Progression (FP, P=6.8e-08, HR=1.7) and Post Progression Survival (PPS, P=0.017, HR=1.36) (Figure 6C).